{
    "xml": "<topic id=\"PHP1672\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/bezafibrate\" basename=\"bezafibrate\" title=\"BEZAFIBRATE\">\n<title>BEZAFIBRATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_596\" namespace=\"/interactions/list-of-drug-interactions/lipid-regulating-drugs/fibrates/bezafibrate\">Bezafibrate</xref>\n</p>\n<data name=\"vtmid\">319937007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_616638065\" title=\"Fibrates\">Fibrates</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP54995\" outputclass=\"drugAction\" rev=\"1.5\" parent=\"/drugs/bezafibrate\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Fibrates act by decreasing serum triglycerides; they have variable effect on LDL-cholestrol.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54944\" outputclass=\"indicationsAndDose\" rev=\"1.18\" parent=\"/drugs/bezafibrate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunct to diet and other appropriate measures in mixed hyperlipidaemia if statin contra-indicated or not tolerated</p>\n<p outputclass=\"therapeuticIndication\">Adjunct to diet and other appropriate measures in severe hypertriglyceridaemia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using immediate-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8239;mg 3 times a day.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By mouth using modified-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;mg once daily, modified-release dose form is not appropriate in patients with renal impairment.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP55017\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/bezafibrate\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Gall bladder disease</ph>; <ph outputclass=\"contraindication\">hypoalbuminaemia</ph>; <ph outputclass=\"contraindication\">nephrotic syndrome</ph>; <ph outputclass=\"contraindication\">photosensitivity to fibrates</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP55051\" outputclass=\"cautions\" rev=\"1.8\" parent=\"/drugs/bezafibrate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Correct hypothyroidism before initiating treatment</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54917\" outputclass=\"interactions\" rev=\"1.5\" parent=\"/drugs/bezafibrate\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (fibrates).</p>\n<p>Combination of a fibrate with a statin increases the risk of muscle effects (especially rhabdomyolysis) and should be used with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54826\" outputclass=\"sideEffects\" rev=\"1.6\" parent=\"/drugs/bezafibrate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal distension</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>; <ph outputclass=\"sideEffect\">nausea</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Alopecia</ph>; <ph outputclass=\"sideEffect\">cholestasis</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">erectile dysfunction</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">myotoxicity (with myasthenia, myalgia, or very rarely rhabdomyolysis)&#8212;special risk in renal impairment</ph>; <ph outputclass=\"sideEffect\">photosensitivity reactions</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">renal failure</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Pancreatitis</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaemia</ph>; <ph outputclass=\"sideEffect\">gallstones</ph>; <ph outputclass=\"sideEffect\">increased platelet count</ph>; <ph outputclass=\"sideEffect\">interstitial lung disease</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">pancytopenia</ph>; <ph outputclass=\"sideEffect\">Stevens-Johnson syndrome</ph>; <ph outputclass=\"sideEffect\">thrombocytopenic purpura</ph>; <ph outputclass=\"sideEffect\">toxic epidermal necrolysis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54902\" outputclass=\"pregnancy\" parent=\"/drugs/bezafibrate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturers advise avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP55066\" outputclass=\"breastFeeding\" parent=\"/drugs/bezafibrate\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54969\" outputclass=\"hepaticImpairment\" parent=\"/drugs/bezafibrate\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in severe liver disease.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54840\" outputclass=\"renalImpairment\" parent=\"/drugs/bezafibrate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Reduce dose to 400&#8239;mg daily if eGFR 40&#8211;60&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n<p>Reduce dose to 200&#8239;mg every 1&#8211;2 days if eGFR 15&#8211;40&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid <i>immediate-release</i> preparations if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n<p>Avoid <i>modified-release</i> preparations if eGFR less than 60&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Myotoxicity</p>\n<p>Special care needed in patients with renal disease, as progressive increases in serum creatinine concentration or failure to follow dosage guidelines may result in myotoxicity (rhabdomyolysis); discontinue if myotoxicity suspected or creatine kinase concentration increases significantly.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP54791\" outputclass=\"monitoringRequirements\" parent=\"/drugs/bezafibrate\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Consider monitoring of liver function and creatine kinase when fibrates used in combination with a statin.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57329\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.9\" parent=\"/drugs/bezafibrate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Fibrates are mainly used in those whose serum-triglyceride concentration is greater than 10&#8239;mmol/litre or in those who cannot tolerate a statin (specialist use).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP1672-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/bezafibrate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76650\" title=\"Tablet\" namespace=\"/drugs/bezafibrate/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76657\" title=\"Modified-release tablet\" namespace=\"/drugs/bezafibrate/modified-release-tablet\">Modified-release tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_596\" namespace=\"/interactions/list-of-drug-interactions/lipid-regulating-drugs/fibrates/bezafibrate\" title=\"Bezafibrate\" count=\"1\" rel=\"link\">Bezafibrate</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76650\" namespace=\"/drugs/bezafibrate/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76657\" namespace=\"/drugs/bezafibrate/modified-release-tablet\" title=\"Modified-release tablet\" count=\"1\" rel=\"link\">Modified-release tablet</xref>\n</links>\n</topic>",
    "id": "PHP1672",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/bezafibrate",
    "basename": "bezafibrate",
    "title": "BEZAFIBRATE",
    "interactants": [
        {
            "id": "bnf_int_596",
            "label": "Bezafibrate"
        }
    ],
    "vtmid": "319937007",
    "drugClassification": [
        "Fibrates"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Fibrates act by decreasing serum triglycerides; they have variable effect on LDL-cholestrol.",
                "html": "<p>Fibrates act by decreasing serum triglycerides; they have variable effect on LDL-cholestrol.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Adjunct to diet and other appropriate measures in mixed hyperlipidaemia if statin contra-indicated or not tolerated",
                        "html": "Adjunct to diet and other appropriate measures in mixed hyperlipidaemia if statin contra-indicated or not tolerated"
                    },
                    {
                        "textContent": "Adjunct to diet and other appropriate measures in severe hypertriglyceridaemia",
                        "html": "Adjunct to diet and other appropriate measures in severe hypertriglyceridaemia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using modified-release medicines"
                    ],
                    "textContent": "By mouth using modified-release medicines",
                    "html": "By mouth using modified-release medicines"
                },
                "adult": [
                    {
                        "textContent": "200 mg 3 times a day.",
                        "html": "<p>200&#8239;mg 3 times a day.</p>"
                    },
                    {
                        "textContent": "400 mg once daily, modified-release dose form is not appropriate in patients with renal impairment.",
                        "html": "<p>400&#8239;mg once daily, modified-release dose form is not appropriate in patients with renal impairment.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Gall bladder disease",
                "html": "Gall bladder disease"
            },
            {
                "type": "contraindications",
                "textContent": "hypoalbuminaemia",
                "html": "hypoalbuminaemia"
            },
            {
                "type": "contraindications",
                "textContent": "nephrotic syndrome",
                "html": "nephrotic syndrome"
            },
            {
                "type": "contraindications",
                "textContent": "photosensitivity to fibrates",
                "html": "photosensitivity to fibrates"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Correct hypothyroidism before initiating treatment",
                "html": "Correct hypothyroidism before initiating treatment"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (fibrates).\n\nCombination of a fibrate with a statin increases the risk of muscle effects (especially rhabdomyolysis) and should be used with caution.",
                "html": "<p>Appendix 1 (fibrates).</p><p>Combination of a fibrate with a statin increases the risk of muscle effects (especially rhabdomyolysis) and should be used with caution.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal distension",
                        "html": "Abdominal distension",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "anorexia",
                        "html": "anorexia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Alopecia",
                        "html": "Alopecia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "cholestasis",
                        "html": "cholestasis",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "erectile dysfunction",
                        "html": "erectile dysfunction",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "myotoxicity (with myasthenia, myalgia, or very rarely rhabdomyolysis)&#8212;special risk in renal impairment",
                        "html": "myotoxicity (with myasthenia, myalgia, or very rarely rhabdomyolysis)&#8212;special risk in renal impairment",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "photosensitivity reactions",
                        "html": "photosensitivity reactions",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "renal failure",
                        "html": "renal failure",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ],
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Pancreatitis",
                        "html": "Pancreatitis",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    },
                    {
                        "type": "rare",
                        "textContent": "peripheral neuropathy",
                        "html": "peripheral neuropathy",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Anaemia",
                        "html": "Anaemia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "gallstones",
                        "html": "gallstones",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "increased platelet count",
                        "html": "increased platelet count",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "interstitial lung disease",
                        "html": "interstitial lung disease",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "pancytopenia",
                        "html": "pancytopenia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "Stevens-Johnson syndrome",
                        "html": "Stevens-Johnson syndrome",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "thrombocytopenic purpura",
                        "html": "thrombocytopenic purpura",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "toxic epidermal necrolysis",
                        "html": "toxic epidermal necrolysis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturers advise avoid&#8212;no information available.",
                "html": "<p>Manufacturers advise avoid&#8212;no information available.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in severe liver disease.",
                "html": "<p>Avoid in severe liver disease.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Reduce dose to 400 mg daily if eGFR 40&#8211;60 mL/minute/1.73 m2.\n\nReduce dose to 200 mg every 1&#8211;2 days if eGFR 15&#8211;40 mL/minute/1.73 m2.",
                "html": "<p>Reduce dose to 400&#8239;mg daily if eGFR 40&#8211;60&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p><p>Reduce dose to 200&#8239;mg every 1&#8211;2 days if eGFR 15&#8211;40&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid immediate-release preparations if eGFR less than 15 mL/minute/1.73 m2.\n\nAvoid modified-release preparations if eGFR less than 60 mL/minute/1.73 m2.",
                "html": "<p>Avoid <i>immediate-release</i> preparations if eGFR less than 15&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p><p>Avoid <i>modified-release</i> preparations if eGFR less than 60&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            },
            {
                "type": "generalInformation",
                "title": "Myotoxicity",
                "textContent": "Special care needed in patients with renal disease, as progressive increases in serum creatinine concentration or failure to follow dosage guidelines may result in myotoxicity (rhabdomyolysis); discontinue if myotoxicity suspected or creatine kinase concentration increases significantly.",
                "html": "<p>Special care needed in patients with renal disease, as progressive increases in serum creatinine concentration or failure to follow dosage guidelines may result in myotoxicity (rhabdomyolysis); discontinue if myotoxicity suspected or creatine kinase concentration increases significantly.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Consider monitoring of liver function and creatine kinase when fibrates used in combination with a statin.",
                "html": "<p>Consider monitoring of liver function and creatine kinase when fibrates used in combination with a statin.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Fibrates are mainly used in those whose serum-triglyceride concentration is greater than 10 mmol/litre or in those who cannot tolerate a statin (specialist use).",
                "html": "<p>Fibrates are mainly used in those whose serum-triglyceride concentration is greater than 10&#8239;mmol/litre or in those who cannot tolerate a statin (specialist use).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76650",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76657",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_596",
                "label": "Bezafibrate",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76650",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76657",
                "label": "Modified-release tablet",
                "type": "medicinalForm"
            }
        ]
    }
}